对疑似痴呆症的评估
E Seth Kramer1, Melissa N Johnson1, Bradford Winslow1
1University of Colorado Anschutz School of Medicine, Aurora.
American family physician
|January 14, 2026
概括
痴呆症评估包括识别早期症状和使用查工具. 进一步评估包括病史,检查,实验室测试和脑部成像,以区分与可逆性疾病.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
- 认知科学 认知科学
背景情况:
- 痴呆症是一个重要的神经认知障碍,影响日常生活.
- 衰老是主要的危险因素;其他因素包括遗传学,心血管健康,糖尿病和教育.
- 早期发现微妙的迹象至关重要,因为它们经常被误认为是正常的衰老.
研究的目的:
- 概述痴呆症的综合评估过程.
- 区分痴呆症与其他认知障碍和可逆性疾病.
- 引导临床医生选择适当的诊断工具和干预措施.
主要方法:
- 使用像Mini-Cog和Memory Impairment Screen (MIS) 这样的工具进行初始查.
- 详细的认知评估工具,如MoCA,SLUMS,或RUDAS如果怀疑损害.
- 综合患者病史,药物审查,身体和神经学检查.
- 实验室检测 (例如,维生素B12,甲状腺功能) 和脑成像 (MRI或CT) 排除二次原因.
主要成果:
- 微妙的认知缺陷可能会被错过或被错误地归因于正常的衰老.
- 结合查,详细评估和客观测试的多方面方法是准确诊断所必需的.
- 将痴呆症与抑郁症和妄想等可逆性疾病区分开来是一个关键的挑战.
结论:
- 早期和准确的痴呆症诊断对于及时管理至关重要.
- 系统评估包括查工具,临床评估,实验室测试和成像,可以提高诊断准确度.
- 在特定的临床情景中建议转诊神经科医生,包括早期症状或诊断不确定性.
相关概念视频
01:30Dementia
515
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
515
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811